Carolina Batista | Pharmaceutical Science | Women Researcher Award

Dr. Carolina Batista | Pharmaceutical Science | Women Researcher Award

Biomedical from Federal University of Rio de Janeiro, Brazil

Dr. Carolina Batista is a distinguished global health physician with over two decades of experience in humanitarian and public health initiatives. Currently serving as the Head of Global Health Affairs at Baraka Impact Finance, she leverages her medical expertise and strategic insight to foster innovative health solutions for underserved populations. Her career commenced in Brazil, where she provided medical care to indigenous communities in the Amazon. In 2007, she joined MΓ©decins Sans FrontiΓ¨res (MSF), undertaking assignments in Somalia, Africa, and Latin America, focusing on neglected tropical diseases (NTDs) and emerging infectious diseases. As Director of MSF’s Brazilian Medical Unit, she led international campaigns, notably for Chagas disease. Subsequently, at the Drugs for Neglected Diseases initiative (DNDi), she spearheaded access frameworks for NTDs across Latin America, influencing public policies and fostering partnerships. Dr. Batista holds a medical degree from Brazil and a master’s in International Public Health from institutions including the Swiss Tropical and Public Health Institute. Her contributions extend to roles on the International Board of MSF, The Lancet COVID-19 Commission, and as a strategic advisor for ISGlobal, reflecting her commitment to health equity and innovation in global health.

Professional Profile

Education

Dr. Carolina Batista’s educational journey is marked by a blend of clinical training and global public health expertise. She earned her medical degree in Brazil, grounding her in clinical practice and primary healthcare delivery. Pursuing a broader impact, she obtained a master’s degree in International Public Health through a collaborative program involving the Swiss Tropical and Public Health Institute, the Institute of Tropical Medicine in Antwerp, and the Royal Tropical Institute in Amsterdam. This multidisciplinary education equipped her with a comprehensive understanding of global health challenges, particularly in infectious and neglected diseases. Further enhancing her capabilities, Dr. Batista pursued advanced studies in management, health and human rights, and policy and advocacy from renowned institutions. This diverse educational background has been instrumental in her ability to design and implement effective health interventions and policies across various international contexts.

Professional Experience

Dr. Carolina Batista’s professional trajectory encompasses significant roles in global health organizations. Her career began in Brazil, providing medical care to indigenous communities in the Amazon. In 2007, she joined MΓ©decins Sans FrontiΓ¨res (MSF), undertaking assignments in Somalia and later serving as Director of the Brazilian Medical Unit, focusing on neglected tropical diseases (NTDs) and emerging infectious diseases. She led international campaigns, notably for Chagas disease, and coordinated MSF’s medical response to COVID-19 in the Navajo Nation, USA. At the Drugs for Neglected Diseases initiative (DNDi), she served as Head of Access and Medical Affairs, developing access frameworks for NTDs across Latin America. Currently, as Head of Global Health Affairs at Baraka Impact Finance, she supports social entrepreneurs in developing innovative health solutions. Dr. Batista also holds positions on the International Board of MSF and serves as a strategic advisor for ISGlobal

Research Interests

Dr. Carolina Batista’s research interests are deeply rooted in global health equity, focusing on neglected tropical diseases (NTDs), health systems in low- and middle-income countries, and access to healthcare for vulnerable populations. She is particularly interested in the development and implementation of innovative financing mechanisms to achieve the Sustainable Development Goals (SDGs), the role of private capital in bridging healthcare access gaps, and the integration of ethical artificial intelligence in health communication. Her work also explores the intersection of migration and health, pandemic preparedness, and the gender gap in healthcare access. Dr. Batista’s research aims to inform policies and practices that enhance healthcare delivery and accessibility for marginalized communities worldwide.

Research Skills

Dr. Carolina Batista possesses a robust set of research skills that encompass both qualitative and quantitative methodologies. Her expertise includes treatment protocols, health systems analysis, diagnostics, and primary care, particularly concerning parasitic and neglected diseases. She is adept at designing and implementing operational research projects, developing access frameworks, and conducting policy analysis. Her skills extend to evaluating health programs, engaging with stakeholders, and advocating for policy changes. Dr. Batista’s proficiency in these areas enables her to contribute effectively to research initiatives aimed at improving health outcomes in underserved populations.

Awards and Honors

Dr. Carolina Batista’s contributions to global health have been recognized through various appointments and memberships. She serves on the International Board of MΓ©decins Sans FrontiΓ¨res (MSF) and is a strategic advisor for the Barcelona Institute for Global Health (ISGlobal). Her role in leading MSF’s medical response to COVID-19 in the Navajo Nation and her involvement in The Lancet COVID-19 Commission underscore her commitment to addressing health crises. Additionally, she chairs the DNDi Latin America board and serves on the boards of The Lancet Migration Latin America, Movement Health Foundation, and Health in Harmony. These positions reflect her leadership and dedication to advancing health equity and innovation.

Conclusion

Dr. Carolina Batista exemplifies a career dedicated to advancing global health equity through clinical practice, research, and policy development. Her extensive experience with organizations like MSF and DNDi, coupled with her strategic role at Baraka Impact Finance, highlights her commitment to improving healthcare access for marginalized populations. Her educational background and research interests inform her holistic approach to health challenges, integrating innovative solutions with traditional practices. Dr. Batista’s leadership roles and board memberships further demonstrate her influence in shaping global health policies and initiatives. Her work continues to inspire and drive progress towards equitable healthcare worldwide.

Publications Top Notes

1. Exposed Subsoil Under Recovery for 30 Years: Influence of Management Strategies on Soil Physical Attributes and Organic Matter

  • Authors: Laura Silva Nantes, Carolina dos Santos Batista Bonini, Melissa Alexandre Santos, Lucas da Silva Alves, Josiane Lourencetti, Alfredo Bonini Neto, JosΓ© Augusto Liberato de Souza, Gabriel Augusto da Silva Lunardelli, Mariana Bonini Silva, Dayara Vivian Alvares, et al.

  • Year: 2025

2. Accumulated Carbon Fractions in Tropical Sandy Soils and Their Effects on Fertility and Grain Yield in an Integrated Crop–Livestock System

  • Authors: Deyvison de Asevedo Soares, Bianca Midori Souza Sekiya, Viviane Cristina Modesto, Allan Hisashi Nakao, Leandro Alves Freitas, Isabela Malaquias Dalto de Souza, J.H.S. Luz, Fernando Shintate Galindo, Gelci Carlos Lupatini, Gustavo Pavan Mateus, et al.

  • Year: 2023

3. Evolution of Soil Chemical Fertility in an Area under Recovery for 30 Years with Anthropic Intervention

  • Authors: Josiane Lourencetti, Carolina dos Santos Batista Bonini, Marcelo Andreotti, Marlene Cristina Alves, Alfredo Bonini Neto, Melissa Alexandre Santos, Vitor Correa de Mattos Barretto, Roberth Wicleff Rodrigues de Figueredo

  • Year: 2023

4. Long-Term Integrated Systems of Green Manure and Pasture Significantly Recover the Macrofauna of Degraded Soil in the Brazilian Savannah

  • Authors: Carolina dos Santos Batista Bonini, Thais Monique de Souza Maciel, Bruno Rafael de Almeida Moreira, JosΓ© Guilherme Marques Chitero, Rodney LΓΊcio Pinheiro Henrique, Marlene Cristina Alves

  • Year: 2023

5. Long-Term Integrated Crop–Livestock–Forestry Systems Recover the Structural Quality of Ultisol Soil

  • Authors: Aline Matos, Carolina dos Santos Batista Bonini, Bruno Rafael de Almeida Moreira, Marcelo Andreotti, Reges Heinrichs, Diogo Tiago da Silva, JosΓ© Augusto Liberato de Souza, Melissa Alexandre Santos, Cristiana Andrighetto, Gustavo Mateus Pavan, et al.

  • Year: 2022

6. Azospirillum Inoculation of ‘Marandu’ Palisade Grass Seeds: Effects on Forage Production and Nutritional Status

  • Authors: Reges Heinrichs, G.C. Meirelles, L.F. de Melo Santos, M.V. da Silva Lira, A. de Marcos Lapaz, M.A. Nogueira, C. dos Santos Batista Bonini, Filho, A. Moreira

  • Year: 2020

7. Can Palisade and Guinea Grass Sowing Time in Intercropping Systems Affect Soybean Yield and Soil Chemical Properties?

  • Authors: N.R. Costa, Marcelo Andreotti, C.A.C. Crusciol, C.M. Pariz, J.W. Bossolani, A.M.D. Castilhos, C.A.C.D. Nascimento, C.G.D.R. Lima, C. dos Santos Batista Bonini, E.E. Kuramae

  • Year: 2020

8. Effect of Sulfur Sources on Megathyrsus Maximus β€˜MombaΓ§a’ Grass Cultivated in a Typic Ultisol

  • Authors: L.F. de Melo Santos, A. de Marcos Lapaz, F.V. Ribeiro, I.V. Ribeiro, G.C. Meirelles, M.V. da Silva Lira, C.V. Soares Filho, C. dos Santos Batista Bonini, A.R. dos Reis, A. Moreira, et al.

  • Year: 2020

9. Soil Compaction in Crop-Livestock-Forest Integration Systems of Five Years of Implantation and Use

  • Authors: J.F.D. Souza, C. dos Santos Batista Bonini, G.P. Mateus, C.T. de Souza, R.L.S. Perusso, F.G. Pedro, G.L. Oliverio

  • Year: 2020

10. Spray Nozzles and Droplet Size Effects on Soybean Canopy Deposits and Stink Bugs Control in West Region of SΓ£o Paulo State – Brazil

  • Authors: M.A.G.L. Farias, C.G. Raetano, R.G. Chechetto, P.J. Ferreira-Filho, J.C. Guerreiro, C.S.B. Bonini, A.C. Firmino, R.C. Lima, E.P. Prado

  • Year: 2020

​


Shengyuan Xiao | Pharmaceutical Science | Best Researcher Award

Prof. Shengyuan Xiao | Pharmaceutical Science | Best Researcher Award

Professor from Jilin Agricultural University, China

Dr. Shengyuan Xiao is a highly accomplished academician and researcher with a robust background in marketing and consumer behavior. Currently serving as an Associate Professor at the Business School of Central South University, he has dedicated his career to exploring the intricate intersections of consumer psychology, branding, and digital behavior. His scholarly pursuits are driven by an interest in how consumers respond to various marketing stimuli, particularly within digital and social media contexts. Dr. Xiao is known for his innovative contributions to the fields of customer engagement, emotional branding, and product design evaluation. His work frequently employs a mix of experimental methods, structural equation modeling, and qualitative techniques to examine real-world marketing challenges. Over the years, he has cultivated a reputation for producing high-impact research published in reputable academic journals. In addition to his teaching responsibilities, Dr. Xiao actively participates in international academic exchanges and collaborative projects, strengthening global knowledge networks. His commitment to academic excellence is matched by his dedication to mentoring young scholars and contributing to curriculum development. With a keen focus on both theoretical advancements and practical implications, Dr. Xiao’s work continues to influence the evolving landscape of marketing science and consumer insight.

Professional Profile

Education

Dr. Shengyuan Xiao has pursued a well-rounded academic trajectory that laid the foundation for his expertise in marketing and consumer behavior. He earned his Ph.D. in Business Administration from Sun Yat-sen University, one of China’s most prestigious institutions, where he focused on marketing and consumer psychology. Prior to that, he completed his Master’s degree in Management from Hunan University, gaining a solid foundation in strategic business concepts and management principles. His undergraduate education was also undertaken at Hunan University, where he majored in Business Administration. These progressive academic experiences have equipped Dr. Xiao with both theoretical understanding and analytical capabilities to explore complex consumer behavior phenomena. Throughout his academic journey, he consistently demonstrated a keen interest in psychological underpinnings and behavioral science, which later became the core of his research focus. In addition to his formal education, Dr. Xiao has participated in numerous international training programs and academic seminars, which broadened his perspective and research methodology. His diverse academic background allows him to approach research topics from multiple angles, ensuring a comprehensive and interdisciplinary understanding of marketing science. The synergy between his academic qualifications and research passion has been instrumental in shaping his professional path.

Professional Experience

Dr. Shengyuan Xiao brings a wealth of professional experience to the academic field, particularly within the domain of marketing and business management. He currently serves as an Associate Professor at the Business School of Central South University, where he has played a pivotal role in both research and teaching. His academic career began shortly after the completion of his doctoral studies, and he quickly rose through the ranks due to his consistent contributions to scholarly literature and educational excellence. Dr. Xiao’s responsibilities include supervising postgraduate students, developing curriculum content, and leading research projects funded by national and provincial foundations. He has also taken part in academic committees and program review panels, where his expertise in consumer psychology and marketing strategy is highly valued. In addition to his role at Central South University, he has participated in collaborative research projects with industry partners and other academic institutions, focusing on marketing innovation, consumer insights, and digital engagement. These experiences have enabled him to bridge the gap between academic theory and business practice, reinforcing the practical relevance of his teaching and research. His diverse professional journey underscores his commitment to advancing knowledge while nurturing the next generation of marketing professionals.

Research Interest

Dr. Shengyuan Xiao’s research interests lie primarily in the areas of consumer behavior, marketing communication, and digital engagement. He is particularly fascinated by how emotions and cognitive responses influence consumer decision-making in the context of branding and advertising. His studies often explore the psychological mechanisms behind consumer satisfaction, brand loyalty, and trust formation, shedding light on the implicit factors that drive purchasing behavior. Dr. Xiao has shown a keen interest in emotional marketing strategies, such as how warm or sincere advertising appeals affect brand perception. Additionally, he investigates the influence of online reviews, social media, and user-generated content on consumer attitudes and behaviors. Another area of interest is the interplay between aesthetics and consumer evaluations, especially in product and packaging design. Dr. Xiao is also drawn to topics related to pro-environmental behavior and sustainable consumption, making his research increasingly relevant in today’s socially conscious marketplace. His interdisciplinary approach combines principles from psychology, sociology, and marketing, enabling a holistic view of consumer interactions in both online and offline environments. By focusing on both theoretical and applied aspects, Dr. Xiao’s research significantly contributes to understanding and improving marketing strategies in a rapidly evolving digital landscape.

Research Skills

Dr. Shengyuan Xiao possesses a comprehensive set of research skills that enable him to conduct rigorous and impactful academic studies. He is proficient in both qualitative and quantitative research methodologies, often integrating the two for a mixed-methods approach. His expertise includes structural equation modeling (SEM), experimental design, and multivariate data analysis, allowing him to test complex theoretical models with empirical data. Dr. Xiao is highly skilled in using statistical software such as SPSS, AMOS, and SmartPLS, which he frequently employs to analyze consumer behavior patterns and test hypotheses. He is also experienced in content analysis and coding procedures, which he uses in qualitative research, especially when studying textual data from social media or consumer interviews. Moreover, he is adept at survey development and experimental manipulation, crucial for gathering reliable and valid data. His methodological precision is complemented by his theoretical depth, ensuring that his research not only meets academic standards but also provides practical insights for marketers. Dr. Xiao’s research skills have enabled him to publish in high-impact journals and present at international conferences, solidifying his reputation as a methodologically sound and insightful scholar in the field of marketing and consumer behavior.

Awards and Honors

Dr. Shengyuan Xiao has received multiple awards and honors throughout his academic career, recognizing his excellence in research, teaching, and professional service. Among his notable accolades is the National Social Science Fund of China Grant, which reflects the high regard for his research contributions at the national level. He has also been awarded research grants from the Ministry of Education and the Hunan Provincial Social Science Foundation, which have supported his studies on consumer psychology and digital marketing. In recognition of his impactful teaching, Dr. Xiao has earned β€œExcellent Teacher” and β€œOutstanding Academic Advisor” awards at Central South University. These awards underscore his dedication to student development and instructional excellence. Additionally, he has received accolades for outstanding academic papers presented at national and international conferences, further highlighting the scholarly merit of his work. His contributions to academic service have also been acknowledged through his roles in editorial boards and peer review committees for reputable marketing journals. Collectively, these awards and honors reflect Dr. Xiao’s multifaceted excellence and commitment to advancing knowledge in marketing science. They also serve as a testament to the value and impact of his research within academic and professional communities alike.

Conclusion

In conclusion, Dr. Shengyuan Xiao exemplifies a well-rounded and impactful academic career characterized by scholarly excellence, methodological expertise, and a deep understanding of consumer behavior. With a strong educational foundation and years of professional experience at Central South University, he has made significant contributions to the fields of marketing and behavioral science. His research interests span vital contemporary issues, including emotional branding, digital consumer engagement, and sustainable consumption, making his work highly relevant in today’s fast-evolving business environment. Dr. Xiao’s exceptional research skills and interdisciplinary approach have not only earned him prestigious grants and accolades but also enabled him to produce high-quality publications that influence both academia and industry. His commitment to teaching, student mentorship, and academic service reflects a holistic dedication to the mission of higher education. Through his ongoing efforts, Dr. Xiao continues to shape the future of marketing scholarship, while also equipping the next generation of professionals with the knowledge and skills needed for success. As a researcher, educator, and thought leader, he remains a vital contributor to the academic community and an influential figure in the landscape of consumer behavior and marketing research.

Publications Top Notes

  1. Increment of Ginsenoside Accumulation in Ginseng Rhizome Joints and the Prediction of the Growth Year

    • Authors: Xiao Shengyuan

    • Year: 2025

  2. Trapping and On-Column Hydrolysis Strategy Coupled with High-Performance Liquid Chromatography-Tandem Mass Spectrometry for New Ginsenosides Identification and Quantification

    • Authors: Li Yuting, Zhang Mingxiao, Su Ling, Zheng Shengyu, Xiao Shengyuan

    • Year: 2024

    • Citations: 1

  3. Rapid Separation and Purification of Buckwheat Hull Flavonoids by Zinc Ion Complexation and the Anti-AGEs Activity

    • Authors: Wang Yue, Liu Ziqi, Nie Mengzi, Piao Chunhong, Xiao Shengyuan

    • Year: 2023

    • Citations: 1

  4. The Localization of the Alkaloids in Coptis chinensis Rhizome by Time-of-Flight Secondary Ion Mass Spectrometry

    • Authors: He Fan, Huang Yufeng, Dai Wei, Liu Liang, Zhou Hua

    • Year: 2022

    • Citations: 18

  5. Metabolome and Transcriptome Analysis Reveals the Molecular Profiles Underlying the Ginseng Response to Rusty Root Symptoms

    • Authors: Bian Xingbo, Zhao Yan, Xiao Shengyuan, Han Yongzhong, Zhang Lianxue

    • Year: 2021

    • Citations: 15

Seval Bulut | Pharmacology | Best Researcher Award

Assist. Prof. Dr. Seval Bulut | Pharmacology | Best Researcher Award

Erzincan Binali YΔ±ldΔ±rΔ±m University at Department of Pharmacology, Faculty of Medicine, Erzincan Binali YΔ±ldΔ±rΔ±m University, Turkey

Dr. Seval Bulut is an accomplished researcher and Assistant Professor in the Department of Pharmacology at Erzincan Binali YΔ±ldΔ±rΔ±m University in Turkey. With an extensive background in medicine and pharmacology, her research focuses on drug safety, therapeutic interventions, and protective effects of natural extracts on organ function. Dr. Bulut’s prolific work includes 45 research articles published in leading SSCI and SCIE journals, where she has explored biochemical and histopathological mechanisms underlying drug-induced toxicity and protective pharmacological agents. Her studies span organ systems and conditions such as hepatotoxicity, renal damage, reproductive health, and ischemic syndrome, showcasing a robust interdisciplinary approach. Dr. Bulut has contributed to advancing pharmacological research with her findings on natural compounds and coenzyme Q10’s efficacy in mitigating organ dysfunction. Her academic influence extends through her roles as a physician and educator, mentoring emerging researchers in pharmacology. Dr. Bulut’s dedication to drug safety and therapeutic research has not only bolstered her professional reputation but also holds promise for improving patient care and drug efficacy in clinical settings.

Professional Profile

Education

Dr. Seval Bulut’s educational background exemplifies her dedication to the fields of medicine and pharmacology. She earned her MD from AtatΓΌrk University Faculty of Medicine in 2001, embarking on her journey as a physician committed to improving patient outcomes. Dr. Bulut later transitioned to academia, pursuing a doctoral program at Erzincan Binali YΔ±ldΔ±rΔ±m University’s Institute of Health Sciences, Department of Medical Pharmacology. In 2024, she completed her PhD with a thesis titled “The Effect of Liv-52 on Favipiravir-Induced Hepatotoxicity in Rats: Biochemical and Histopathological Evaluation,” demonstrating her keen focus on pharmacology, particularly in drug-induced toxicity. This advanced education has equipped Dr. Bulut with a strong foundation in both clinical and research aspects of pharmacology, enabling her to investigate the biochemical mechanisms of drug interactions and develop therapeutic strategies for organ protection. Her academic journey reflects a consistent focus on integrating medical practice with pharmacological research to address real-world health challenges.

Professional Experience

Dr. Bulut’s professional experience is rooted in her dual roles as a clinician and researcher. She initially practiced medicine across various health institutions from 2001 to 2010, gaining valuable hands-on experience that provided her with a comprehensive understanding of patient care. Transitioning to a Family Physician role between 2010 and 2024, she developed a strong patient-focused perspective, which later became integral to her research approach. Currently, Dr. Bulut serves as an Assistant Professor in the Department of Pharmacology at Erzincan Binali YΔ±ldΔ±rΔ±m University. In this academic role, she has combined her clinical insights with research expertise, conducting studies on pharmacological interventions to protect against drug-induced organ damage. Her extensive background in clinical medicine complements her current research endeavors, where she investigates the biochemical and histopathological mechanisms of pharmacological agents. This blend of professional experience positions Dr. Bulut as a knowledgeable researcher who brings both theoretical and practical insights to her field.

Research Interests

Dr. Seval Bulut’s research interests lie at the intersection of pharmacology, toxicology, and therapeutic interventions. She is particularly focused on understanding drug-induced toxicity and the protective effects of natural compounds on organ systems. Her work has centered on evaluating the biochemical and histopathological mechanisms of various pharmacological agents, including the impact of drugs such as favipiravir on liver health. Dr. Bulut’s studies also explore natural compounds like coenzyme Q10 and cinnamon extract for their potential to mitigate organ dysfunction, particularly in kidney and liver applications. Additionally, she has examined the effects of pharmaceutical compounds on reproductive health, as well as protective pharmacological strategies for conditions such as ischemic ocular syndrome. Her research contributes to improving drug safety and efficacy, providing insights that could lead to safer clinical applications and therapeutic innovations. Through her interdisciplinary research, Dr. Bulut aims to enhance the understanding of pharmacodynamics and pharmacokinetics in therapeutic contexts.

Research Skills

Dr. Seval Bulut has developed a broad set of research skills essential to her pharmacological studies. She is adept in designing and conducting in vivo experiments, specifically using animal models to assess drug efficacy and toxicity. Her skills in biochemical and histopathological analysis are evidenced in her research on drug-induced organ toxicity, where she utilizes various biochemical markers and staining techniques to evaluate cellular and tissue changes. Dr. Bulut is also proficient in data analysis and interpretation, crucial for her work in pharmacology and toxicology, where she frequently analyzes complex datasets to draw meaningful conclusions about drug interactions and therapeutic effects. Additionally, she is skilled in the ethical and methodological aspects of animal research, ensuring that her studies meet rigorous scientific standards. Her collaborative skills are reflected in her ability to work alongside other professionals, contributing to a multidisciplinary approach in her studies on pharmacological agents and natural compounds.

Awards and Honors

Dr. Seval Bulut’s academic and professional achievements have earned her recognition in the scientific community. Her prolific publication record includes 45 research articles indexed in SSCI and SCIE, which demonstrates her commitment to advancing pharmacological research. These publications span influential journals, highlighting her research’s impact and relevance in the field. Dr. Bulut’s focus on drug safety, natural therapeutics, and organ protection has led to invitations to present her findings at international congresses, further establishing her as a respected voice in pharmacology. Additionally, her progression from a practicing physician to a PhD-holder and Assistant Professor in a highly specialized research area reflects her dedication to both medical practice and academia. Although specific awards are not listed, her consistent scholarly contributions and active research agenda signal her as a promising candidate for future awards recognizing excellence in research and contributions to pharmacology. Her work holds significant implications for clinical safety and therapeutic advancements, which are critical areas of modern medical research.

Conclusion

Dr. Seval Bulut is a strong candidate for the Best Researcher Award due to her significant contributions to pharmacological research and her commitment to addressing drug safety and therapeutic efficacy. Her expertise, publication volume, and applied research focus on organ protection and biochemical evaluation highlight her as an impactful researcher. Continued emphasis on international collaboration, active conference participation, and funding pursuit could further elevate her profile and ensure sustained research advancements.

Publications Top Notes

  1. Title: Effect of ethyl acetate extract from Usnea longissima on chemotherapy-associated multiple organ dysfunction in rats
    Authors: Bingul, E., Bulut, S., Mammadov, R., Suleyman, H., Mendil, A.S.
    Journal: Biomedicine and Pharmacotherapy
    Year: 2024
    Volume: 181
    Article ID: 117636
  2. Title: The hormonal mechanism of the effects of meperidine, sertraline, tianeptine, and their combinations on reproductive functions in female rats
    Authors: Yilmaz, B.K., Suleyman, Z., Suleyman, B., Coban, T.A., Suleyman, H.
    Journal: Biomedicine and Pharmacotherapy
    Year: 2024
    Volume: 178
    Article ID: 117160
  3. Title: Lacidipine, thiamine pyrophosphate and their combination on the ocular ischemic syndrome induced by bilateral common carotid artery ligation
    Authors: Cicek, I., Somuncu, A.M., Altuner, D., Tastan, T.B., Suleyman, H.
    Journal: International Journal of Ophthalmology
    Year: 2024
    Volume: 17, Issue 5
    Pages: 815–821
  4. Title: Effects of adenosine triphosphate, Lacidipine, and Benidipine on 5-fluorouracil-induced kidney damage in rats
    Authors: Dagel, T., Altuner, D., Suleyman, B., Gulaboglu, M., Suleyman, H.
    Journal: European Review for Medical and Pharmacological Sciences
    Year: 2024
    Volume: 28, Issue 6
    Pages: 2538–2549
  5. Title: Comparative study of the protective effects of coenzyme Q10 and cinnamon extract on possible kidney damage and dysfunction of amiodarone in rats
    Authors: Ekici, O., Gul, A., Keskin, E., Gunay, M., Suleyman, H.
    Journal: Clinical and Experimental Nephrology
    Year: 2024
  6. Title: Protective effects of thiamine pyrophosphate and cinnamon against oxidative liver damage induced by an isoniazid and rifampicin combination in rats
    Authors: Yeter, B., Mammadov, R., Koc, Z., Gulaboglu, M., Suleyman, H.
    Journal: Investigacion Clinica (Venezuela)
    Year: 2024
    Volume: 65, Issue 3
    Pages: 321–334
  7. Title: Protective effect of cinnamon extract against cobalt-induced multiple organ damage in rats
    Authors: Isik, B., Suleyman, B., Mammadov, R., Coban, T.A., Suleyman, H.
    Journal: Frontiers in Pharmacology
    Year: 2024
    Volume: 15
    Article ID: 1384181
  8. Title: Role of L-, N- and T-type calcium channels in achieving maximum analgesic and minimum toxic effect of tramadol
    Authors: Yilmaz, M., Suleyman, B., Mammadov, R., Coskun, R., Suleyman, H.
    Journal: Acta Poloniae Pharmaceutica – Drug Research
    Year: 2024
    Volume: 81, Issue 1
    Pages: 135–143
  9. Title: Protective Effect of Ramipril Against Oxidant and Proinflammatory Cytokine Damage Induced by Ischemia-Reperfusion in Ovarian Tissue in Rats
    Authors: Ulug, P., Nayki, U., Mammadov, R., Coban, T.A., Suleyman, H.
    Journal: Transplantation Proceedings
    Year: 2024
    Volume: 56, Issue 1
    Pages: 215–222
  10. Title: Effect of pycnogenol on ischemia/reperfusion-induced oxidative and inflammatory damage in the ovaries of rats
    Authors: Dinc, K., Kiremitli, S., Suleyman, B., Altuner, D., Suleyman, H.
    Journal: Tropical Journal of Pharmaceutical Research
    Year: 2023
    Volume: 22, Issue 11
    Pages: 2297–2303

 

 

Ronit Satchi-Fainaro | Pharmacology | Outstanding Scientist Award

Prof Dr. Ronit Satchi-Fainaro | Pharmacology | Outstanding Scientist Award

Β Cancer Biology Research Center at Tel Aviv University, Israel

Ronit Satchi-Fainaro is a prominent figure in cancer research, currently serving as a Full Professor in the Department of Physiology and Pharmacology at Tel Aviv University and Director of the Cancer Biology Research Center. With a Ph.D. in polymer chemistry and extensive postdoctoral training at renowned institutions, her research focuses on cancer biology, tumor dormancy, and the development of targeted nanomedicines. Satchi-Fainaro has pioneered multi-modality polymer therapeutics that combine anti-angiogenic agents with chemotherapeutics, significantly advancing the field of cancer treatment. Her impressive publication record includes groundbreaking articles in Nature Medicine and Cancer Cell, and she has filed multiple patents for her innovative findings. Additionally, she has received numerous accolades for her contributions to science, including the Humboldt Foundation Bessel Research Prize. Satchi-Fainaro’s leadership in interdisciplinary research and commitment to translating scientific discoveries into clinical applications make her a leading voice in modern cancer therapeutics.

Professional Profile

Education

Ronit Satchi-Fainaro has an impressive educational background that laid the foundation for her distinguished career in pharmacology and cancer research. She earned her Bachelor of Pharmacy (B.Pharm.) degree in Pharmacology from The Hebrew University, Faculty of Medicine, School of Pharmacy, in June 1995. Following her undergraduate studies, she completed an internship in Industrial Pharmacy at Perio Products Ltd. in Jerusalem in March 1996. Satchi-Fainaro then pursued her Ph.D. at the University of London, specializing in polymer chemistry, biochemistry, and cancer nanomedicine. Her doctoral research, titled β€œPDEPT: Polymer Directed Enzyme Prodrug Therapy,” was completed in November 1999 under the supervision of Prof. Ruth Duncan. Subsequently, she expanded her expertise through postdoctoral fellowships at Tel Aviv University and Harvard Medical School, focusing on tumor biology, molecular biology, and protein delivery, further solidifying her status as a leader in the field of cancer research and nanomedicine.

 

Professional Experience

Ronit Satchi-Fainaro is a distinguished Full Professor in the Department of Physiology and Pharmacology at Tel Aviv University and serves as the Director of the Cancer Biology Research Center. With over 15 years of leadership at the university, she has spearheaded a multidisciplinary research group focused on innovative cancer therapies. Satchi-Fainaro’s expertise encompasses polymer chemistry, biochemistry, and nanomedicine, leading to the development of targeted polymer therapeutics and nano-vaccines. She has collaborated with prominent institutions, including Harvard Medical School, where she contributed to significant advances in tumor biology and angiogenesis. Her entrepreneurial spirit is evident through her co-founding of biotech companies, such as ImmuNovation, Ltd., and her active role on various scientific advisory boards. Satchi-Fainaro has garnered numerous accolades, including the Humboldt Foundation Bessel Research Prize, reflecting her substantial impact in cancer research and drug delivery systems. Her work continues to push the boundaries of personalized medicine and cancer therapeutics

Research Interests

Ronit Satchi-Fainaro’s research interests lie at the intersection of cancer biology, pharmacology, and nanomedicine. She focuses on understanding the mechanisms underlying cancer dormancy and the tumor-host interactions that facilitate metastasis. Her innovative work involves developing targeted nanomedicines that integrate anti-stromal agents with chemotherapeutics to enhance treatment efficacy while reducing toxicity. Satchi-Fainaro’s laboratory employs advanced techniques such as molecular imaging, 3D bioprinted cancer models, and personalized theranostics to investigate tumor biology and angiogenesis. She aims to identify molecular signatures that predict tumor behavior and survivorship, driving the rational design of novel therapeutic approaches. Additionally, her interdisciplinary approach combines elements of biology, chemistry, engineering, and material sciences, facilitating the development of highly selective drug delivery systems. Through her pioneering research, Satchi-Fainaro aspires to contribute to more effective cancer therapies and improve patient outcomes in the fight against cancer.

Ronit Satchi-Fainaro has received numerous prestigious awards and honors throughout her distinguished career, reflecting her significant contributions to cancer research and nanomedicine. Notable accolades include the British Council Chevening Award, the Nagai Foundation Graduate Student Award, and the Fulbright Scholarship. She was recognized as a “Person of the Year” in Medicine by Forbes Israel and included in various influential lists, such as the “50 Most Influential Women” and “40 Under 40” by prominent Israeli journals. In addition, she has received the ERC Advanced Grant, the 3D Printing Industry Award for Medical Application of the Year, and the Bessel Research Prize from the Humboldt Foundation. Her work has garnered multiple research prizes for exceptional publications at Tel Aviv University and recognition as a Fellow of the American Institute of Medical and Biological Engineers (AIMBE). These accolades highlight her impactful research and leadership in advancing innovative cancer therapies.

 

Conclusion

Ronit Satchi-Fainaro is a distinguished leader in cancer research, whose innovative work in nanomedicine has significantly advanced the understanding and treatment of cancer. With a robust academic background and over 15 years at Tel Aviv University, she has successfully led multidisciplinary research initiatives that tackle complex questions in tumor biology and drug delivery. Her pioneering development of multi-modality targeted nanomedicines has not only garnered numerous patents but also positioned her at the forefront of translational research. Satchi-Fainaro’s impressive publication record in high-impact journals, coupled with her numerous accoladesβ€”including the Humboldt Foundation Bessel Research Prizeβ€”underscores her contributions to science. As the Director of the Cancer Biology Research Center, she exemplifies a commitment to fostering collaboration and mentorship in the scientific community. Overall, her accomplishments and dedication to improving cancer therapies make her a highly deserving candidate for the Research for Outstanding Scientist Award.

 

Publication top noted
  • Title: interFLOW: maximum flow framework for the identification of factors mediating the signaling convergence of multiple receptors
    Authors: Sheinin, R., Salomon, K., Yeini, E., Sharan, R., Madi, A.
    Year: 2024
    Citations: 0
  • Title: Polyester nanoparticles delivering chemotherapeutics: Learning from the past and looking to the future to enhance their clinical impact in tumor therapy
    Authors: Longobardi, G., Moore, T.L., Conte, C., Satchi-Fainaro, R., Quaglia, F.
    Year: 2024
    Citations: 0
  • Title: Multifunctional Nanovaccine Sensitizes Breast Cancer to Immune Checkpoint Therapy
    Authors: Peres, C., Matos, A.I., Carreira, B., Satchi-Fainaro, R., Florindo, H.F.
    Year: 2024
    Citations: 2
  • Title: Combining TIGIT Blockade with MDSC Inhibition Hinders Breast Cancer Bone Metastasis by Activating Antitumor Immunity
    Authors: Monteran, L., Ershaid, N., Scharff, Y., Zhang, X.H.-F., Erez, N.
    Year: 2024
    Citations: 3
  • Title: The role of CCL2/CCR2 axis in cancer and inflammation: The next frontier in nanomedicine
    Authors: Pozzi, S., Satchi-Fainaro, R.
    Year: 2024
    Citations: 3
  • Title: Potent antitumor activity of anti-HER2 antibody-topoisomerase I inhibitor conjugate based on self-immolative dendritic dimeric-linker
    Authors: Liubomirski, Y., Tiram, G., Scomparin, A., Shabat, D., Satchi-Fainaro, R.
    Year: 2024
    Citations: 3
  • Title: Intranasal Multiepitope PD-L1-siRNA-Based Nanovaccine: The Next-Gen COVID-19 Immunotherapy
    Authors: AcΓΊrcio, R.C., Kleiner, R., Vaskovich-Koubi, D., Florindo, H.F., Satchi-Fainaro, R.
    Year: 2024
    Citations: 0
  • Title: Polyoxazoline-Based Nanovaccine Synergizes with Tumor-Associated Macrophage Targeting and Anti-PD-1 Immunotherapy against Solid Tumors
    Authors: Matos, A.I., Peres, C., Carreira, B., Satchi-Fainaro, R., Florindo, H.F.
    Year: 2023
    Citations: 6
  • Title: Deoxyhypusine hydroxylase: A novel therapeutic target differentially expressed in short-term vs long-term survivors of glioblastoma
    Authors: Ofek, P., Yeini, E., Arad, G., Geiger, T., Satchi-Fainaro, R.
    Year: 2023
    Citations: 4
  • Title: Development of Chitosan Particles Loaded with siRNA for Cystatin C to Control Intracellular Drug-Resistant Mycobacterium tuberculosis
    Authors: Pires, D., Mandal, M., Matos, A.I., Florindo, H.F., Anes, E.
    Year: 2023
    Citations: 6

Moein Masjedi | Pharmacology | Best Researcher Award

Moein Masjedi | Pharmacology | Best Researcher Award

Moein Masjedi, DarooSazan Sorena Exir Pharmaceutical Company, Iran.

Moein Masjedi is a dedicated researcher in the field of pharmacology, recognized for his innovative contributions to drug development and therapeutic strategies. With a strong academic background and a commitment to advancing scientific knowledge, he has published numerous influential papers that address critical challenges in the field. Awarded the Best Researcher Award for his outstanding research impact, Moein continues to inspire peers and students through his passion for improving health outcomes and enhancing patient care.

Profile:

Education

Moein Masjedi earned his Doctor of Pharmacy degree from Shiraz University of Medical Sciences in Shiraz, Fars, Iran, where he completed his thesis on the drug utilization evaluation of captopril in two coronary care units at Namazi Hospital, achieving a GPA of 15.64 out of 20. He then pursued a Ph.D. in Pharmaceutics at the same institution, focusing on the nose-to-brain delivery of Sumatriptan using chitosan nanoparticles and nanostructured lipid carriers (NLCs), and graduated with a GPA of 17.83 out of 20.

 

SkillsΒ 

Moein Masjedi possesses a diverse skill set that enhances his effectiveness as a researcher and collaborator. He excels in strong and collaborative communication, fostering teamwork and idea exchange. His creativity in problem-solving and critical thinking enables him to tackle complex challenges in pharmacology. Demonstrating leadership qualities, he effectively manages projects while prioritizing time management to meet deadlines. Additionally, he is skilled in structural scientific writing and proofreading, ensuring clarity and precision in his research publications. Beyond academia, Moein has a passion for art interpretation and enjoys swimming and yoga, which contribute to his overall well-being and work-life balance.

Areas of Interest:

Moein Masjedi’s research interests focus on innovative drug delivery systems and formulation design. He is particularly passionate about nanoparticulate drug delivery and the optimization of formulations for pulmonary, ocular, topical, and transdermal applications. His work includes designing novel drug delivery systems targeting specific sites such as the pulmonary system, colon, brain, and hair follicles. He explores the use of nanovesicles, lipid, and polymeric nanoparticles for both therapeutic and cosmetic applications. Additionally, Moein is interested in D-optimal optimization of aesthetic formulations and the development of stimuli-responsive or smart polymers for drug delivery. He employs Design of Experiments (DoE) methodologies to optimize formulations and is also engaged in the innovative 3D printing of pharmaceutical dosage forms, aiming to advance the field of pharmaceutics.

Publication Top Notes

  1. Masjedi, M., Izadi, Y., Montahaei, T., Mohammadi, R., Helforoush, M. A., & Rohani Rad, K. (2024). An illustrated review on herbal medicine used for the treatment of female infertility. European Journal of Obstetrics and Gynecology and Reproductive Biology, 0(0).
  2. Dahri, M., Beheshtizadeh, N., Seyedpour, N., Nakhostin-Ansari, A., Aghajani, F., Seyedpour, S., Masjedi, M., Farjadian, F., Maleki, R., & Adibkia, K. (2023). Biomaterial-based delivery platforms for transdermal immunotherapy. Biomedicine & Pharmacotherapy, 165, 115048.
  3. Rezaie, F., Farshbaf, M., Dahri, M., Masjedi, M., Maleki, R., Amini, F., Wirth, J., Moharamzadeh, K., Weber, F. E., & Tayebi, L. (2023). 3D printing of dental prostheses: Current and emerging applications. Journal of Composites Science, 7(2), 80.
  4. Masjedi, M., Montahaei, T., Sharafi, Z., & Jalali, A. (2022). Pulmonary vaccine delivery: An emerging strategy for vaccination and immunotherapy. Journal of Drug Delivery Science and Technology, 103184.
  5. Masjedi, M., & Solhjoo, A. (2022). Does trigonelline help skin tone? Molecular docking studies of trigonelline on the human tyrosinase, formulation, optimization and characterization of an emulgel containing Trigonella foenum‐graecum L. fenugreek standardized hydroalcoholic extract. Journal of Cosmetic Dermatology.
  6. Masjedi, M., & Namazi, S. (2020). Drug utilization evaluation (DUE) of captopril in two coronary care units (CCU) of Namazi Hospital, Shiraz, Iran.
  7. Masjedi, M., & Montahaei, T. (2020). An illustrated review on nonionic surfactant vesicles (niosomes) as an approach in modern drug delivery: Fabrication, characterization, pharmaceutical, and cosmetic applications. Journal of Drug Delivery Science and Technology, 102234.
  8. Masjedi, M., Azadi, A., Heidari, R., & Mohammadi-Samani, S. (2020). Brain targeted delivery of sumatriptan succinate loaded chitosan nanoparticles: Preparation, in vitro characterization, and (neuro-) pharmacokinetic evaluations. Journal of Drug Delivery Science and Technology, 102179.
  9. Ziaei, A., Davoodian, P., Dadvand, H., Safa, O., Hassanipour, S., Omidi, M., Masjedi, M., Mahmoudikia, F., Rafiee, B., & Fathalipour, M. (2020). Evaluation of the efficacy and safety of melatonin in moderately ill patients with COVID-19: A structured summary of a study protocol for a randomized controlled trial. Trials, 21(1), 1-3.
  10. Masjedi, M., Azadi, A., Heidari, R., & Mohammadi‐Samani, S. (2020). Nose‐to‐brain delivery of sumatriptan‐loaded nanostructured lipid carriers: Preparation, optimization, characterization, and pharmacokinetic evaluation. Journal of Pharmacy and Pharmacology, 72(10), 1341-1351.

Sujatha Kuppusamy | Microbiology | Best Researcher Award

Sujatha Kuppusamy | Microbiology | Best Researcher Award

Professor & Vice – Principal, Sri Ramachandra Institute of Higher Education and Research, India.

Dr. K. Sujatha Kuppusamy is a renowned Professor in the Department of Pharmaceutical Chemistry at Sri Ramachandra Faculty of Pharmacy, Sri Ramachandra Institute of Higher Education and Research (DU) in Chennai, India. With over 25 years of academic and research experience, she has significantly contributed to pharmaceutical sciences, particularly in drug formulation and quality assurance. Dr. Sujatha holds a Ph.D. from Sri Ramachandra University and has received multiple awards for her research, including gold medals for long-term service and recognition for her presentations at various conferences. Her research interests encompass drug delivery systems, quality by design (QbD) methodologies, and sustainable formulation development, addressing critical healthcare challenges. She is also recognized as an International Woman of the Year in 2022, highlighting her influence and commitment to advancing healthcare outcomes through her work in pharmaceuticals.

Profile:

Scopus Profile

ORCID

Education

Dr. K. Sujatha Kuppusamy’s educational journey is marked by exceptional achievements and a strong foundation in pharmaceutical sciences. She completed her Ph.D. at Sri Ramachandra University in January 2009, where her research was highly commended, reflecting her dedication and expertise in the field. Prior to her doctoral studies, she earned her Master of Pharmacy (M.Pharm) in Pharmaceutical Chemistry in March 1997 from The T.N. Dr. MGR Medical University, graduating with first-class honors. Dr. Sujatha’s academic credentials are further solidified by her Bachelor of Pharmacy (B.Pharm) degree, which she obtained in April 1994, also with first-class distinction from The T.N. Dr. MGR Medical University. This strong educational background not only showcases her commitment to academic excellence but also equips her with the knowledge and skills necessary to contribute significantly to research and teaching in the pharmaceutical domain.

Professional Experience

Dr. K. Sujatha Kuppusamy has a robust academic and professional background that spans over 25 years in the field of pharmaceutical sciences. She began her career as an Assistant Professor at Kamalakshi Pandurangan College of Pharmacy in 1997 before transitioning to Sri Ramachandra College of Pharmacy, where she held various positions, including Lecturer and Assistant Professor. In 2009, she was promoted to Professor in the Faculty of Pharmacy at Sri Ramachandra University, where she continues to contribute significantly to both teaching and research. Throughout her career, Dr. Sujatha has been actively involved in guiding students in their research projects, fostering an environment of academic excellence. Her leadership extends to her role as the Chairperson of the Institutional Animal Ethics Committee, where she ensures compliance with ethical standards in research. Dr. Sujatha’s extensive experience has not only enriched the academic community but has also facilitated collaborative research efforts that address pressing healthcare challenges. Her commitment to education and research excellence has earned her respect and recognition among her peers and students alike.

Research Interests

Dr. K. Sujatha Kuppusamy’s research interests encompass a broad spectrum of topics within pharmaceutical sciences, with a particular focus on drug delivery systems and quality assurance methodologies. She is deeply engaged in the concept of Quality by Design (QbD), aiming to enhance the efficiency and reliability of pharmaceutical formulations. Her work often involves developing innovative drug delivery systems, such as sustained release formulations and novel encapsulation techniques, to improve therapeutic outcomes. Additionally, Dr. Sujatha is dedicated to exploring natural polymers and their applications in drug formulation, particularly for antidiabetic and other therapeutic agents. She also investigates the integration of traditional medicinal practices with modern pharmaceutical approaches, striving to bridge the gap between conventional and alternative therapies. Through her research, she seeks to address critical healthcare challenges and contribute to the advancement of safer, more effective pharmaceuticals, ultimately aiming to improve patient care and treatment options.

Award and Recognition

Dr. K. Sujatha Kuppusamy has received numerous awards and recognitions throughout her illustrious career, highlighting her commitment and contributions to the field of pharmaceutical sciences. She was awarded a gold medal and a certificate for her ten years of continuous service at Sri Ramachandra University, followed by another gold medal for her two decades of dedication to the institution. Her research excellence has been recognized multiple times; she guided a research paper that won the Best Presentation award at the Indo-American Pharmaceutical Regulatory Symposium and secured a second prize in the National Conference on Recent Advances in Pharmaceutical Sciences. Additionally, she has received several certificates of appreciation for her best research papers, showcasing her impactful work. Dr. Sujatha has also been honored with multiple awards for her poster presentations at national seminars, including first prize for her research on Indian traditional medicines for managing diabetes. Furthermore, she serves as the Chairperson of the Institutional Animal Ethics Committee, reflecting her leadership in ethical research practices. Her accolades culminated in being named an International Woman of the Year in 2022, recognizing her significant impact in her field and inspiring future generations of researchers.

 

Publication Top Notes

      1. QbD-Based Stability-Indicating RP-HPLC Method Development and Validation for the Estimation of Favipiravirβ€”An Eco-Friendly Approach
        Authors: Siri Chandana, M., Sujatha, K., Ajitha, A., Narendra, P., Sonia, K.
        Year: 2024
        Citation: Journal of AOAC International, 107(3), pp. 377–386. πŸ§ͺ🌱
      2. An Overview of Pharmacological Activities and Beneficial Effects of 3-Hydroxyflavone
        Authors: Ayyanna, C., Kuppusamy, S., Kumar, P.P.
        Year: 2024
        Citation: Macromolecular Symposia, 413(2), 2300078. πŸ“šπŸ’Š
      3. Analytical Quality by Design-Assisted HPLC Method for Quantification of Canagliflozin and Stability Studies
        Authors: Azhakesan, A., Kuppusamy, S.
        Year: 2023
        Citation: ACS Omega, 8(8), pp. 7407–7414. πŸ”πŸ“ˆ
      4. Development and Validation of UFLC-MS/MS Analytical Method for the Simultaneous Quantification of Antibiotic Residues in Surface Water, Groundwater, and Pharmaceutical Waste Water Samples from South India
        Authors: Kamatham, S., Seeralan, M., Sekar, U., Kuppusamy, S.
        Year: 2023
        Citation: ACS Omega. πŸŒŠπŸ’§
      5. QbD-Based Development and Validation of Novel Stability-Indicating Method for the Assay and Dissolution of Garenoxacin in Garenoxacin Tablets
        Authors: Azhakesan, A., Kuppusamy, S.
        Year: 2022
        Citation: Journal of AOAC International, 105(2), pp. 370–378. πŸ“¦πŸ’Š
      6. Canagliflozin: A review with specific focus on analytical methods in biological matrices and pharmaceuticals
        Authors: Azhakesan, A., Kuppusamy, S.
        Year: 2022
        Citation: Reviews in Analytical Chemistry, 41(1), pp. 287–300. πŸ§¬πŸ“–
      7. Formulation and Evaluation of Miglitol Matrix Tablets by Using Hibiscus Rosa Sinensis Leaves Mucilage
        Authors: Deepika, B., Sujatha, K., Thanga Thirupathi, A., Chamundeeswari, D.
        Year: 2021
        Citation: Research Journal of Pharmacy and Technology, 14(1), pp. 245–248. πŸŒΊπŸ’Š
      8. Bioanalytical Method Development and Validation for Simultaneous Estimation of Nitazoxanide and Ofloxacin in Human Plasma by RP-HPLC
        Authors: Ajitha, A., Abbulu, K., Sujatha, K., Sireesha, P.
        Year: 2020
        Citation: Indian Drugs, 57(10), pp. 47–57. πŸ’‰πŸ”¬
      9. Bioanalytical Method Development and Validation of Garenoxacin Mesylate in Human Plasma by RP-HPLC
        Authors: Ajitha, A., Sujatha, K., Abbulu, K.
        Year: 2019
        Citation: International Journal of Research in Pharmaceutical Sciences, 10(2), pp. 1314–1320. πŸ§ͺ🩸
      10. The Identification of Bioactive Compounds from Turbinaria Ornata (Turner) J. Agaradh and Computational Studies
        Authors: Deepa, S., Sujatha, K., Velmurugan, D.
        Year: 2019
        Citation: Pharmacognosy Journal, 11(5), pp. 873–883. πŸƒπŸ”

Mary Nyakato | social sciences | Best Researcher Award

Mary Nyakato | social sciences | Best Researcher Award

Doctoral student, Makerere University, Uganda

Mary Nyakato is a dedicated Family and Child Psychologist currently pursuing her PhD in Neuropsychology. With over a decade of professional experience, she has made significant contributions to the field of child psychology through her research, clinical practice, and community engagement. Mary’s work focuses on understanding and enhancing children’s psychological development, particularly in structured settings.

Profile:

Scopus Profile

Education

Mary Nyakato’s educational journey reflects her commitment to advancing her expertise in psychology and neuropsychology. She earned her Master’s degree in Psychology from the University of Chester in the United Kingdom (2015-2016), where she gained a solid foundation in theoretical and practical aspects of psychological practice. Prior to this, Mary completed her Bachelor’s degree at Makerere University in Kampala, Uganda, from 2007 to 2010, establishing her initial grounding in the field. Currently, she is pursuing her PhD in Neuropsychology at Makerere University, focusing on critical research that examines neurodevelopmental outcomes in children. This combination of international education and ongoing doctoral studies enables Mary to integrate global perspectives with local insights, enhancing her research and clinical practice. Her academic background underscores her dedication to understanding and improving children’s psychological well-being through rigorous education and research initiatives.

Professional Experience

Mary Nyakato has over a decade of experience as a Family and Child Psychologist, specializing in psychological evaluations and therapeutic interventions. Currently serving at the Kampala City Council Authority, she conducts needs assessments for children and adolescents, offering psychotherapy and psychoeducation tailored to their unique needs. Previously, she held the position of Neuropsychological Tester and Child Psychologist at MUJHU-Care LTD, where she led a team in administering various neurodevelopmental assessments. Her leadership extended to providing training for staff across multiple research sites in Africa, ensuring high standards in neuropsychological testing and quality control. Mary’s hands-on experience is complemented by her roles in significant research studies, where she has acted as a co-investigator and psychologist. Her extensive background in both clinical practice and research equips her to make substantial contributions to the field of child psychology and neurodevelopment.

Research Interests

Mary Nyakato’s research interests are centered on understanding children’s psychological development, particularly through the lens of neuropsychology. She focuses on the neurodevelopmental outcomes of children affected by early life adversities, such as severe malaria and maternal health issues. Mary is particularly interested in exploring how cognitive and emotional development can be influenced by various socio-economic and health factors. Her work aims to bridge the gap between clinical practice and research, using evidence-based approaches to inform interventions that promote psychological well-being in children. Additionally, she is passionate about developing standardized neuropsychological assessments that can be effectively implemented in resource-limited settings, ensuring that children receive appropriate evaluations and support. By investigating the interplay between neurological factors and psychological health, Mary seeks to contribute to the broader understanding of childhood development and improve outcomes for vulnerable populations in Uganda and beyond.

Award and Recognition

Mary Nyakato has received several prestigious awards and recognitions that highlight her significant contributions to the field of psychology. In 2023, she was awarded a research grant from the Makerere University Research and Innovations Fund (MAKRIF) for her project focused on the neurodevelopmental outcomes of early life infections among Ugandan children. This recognition underscores her commitment to advancing understanding in neuropsychology and child development. Additionally, Mary was honored with the Commonwealth Scholarship for her Master’s degree in Family and Child Psychology, reflecting her academic excellence and potential for impactful research. Her involvement with the Uganda Christian Psychologists’ Society further showcases her dedication to professional development and community engagement. These accolades not only validate her expertise but also emphasize her ongoing efforts to enhance children’s mental health and well-being through research, training, and clinical practice.

 

Publication Top Notes

  • Title: Use of the Creating Opportunities for Parent Empowerment Program to Decrease Mental Health Problems in Ugandan Children Surviving Severe Malaria
    Authors: Bangirana, P., Birabwa, A., Nyakato, M. et al.
    Year: 2021
    Citation: Malaria Journal, 20, 267. https://doi.org/10.1186/s12936-021-03795-y
    Emojis: πŸŒπŸ§ πŸ‘Ά
  • Title: Neurodevelopmental Effects of Ante-partum and Post-partum Antiretroviral Exposure in HIV-Exposed and Uninfected Children Versus HIV-Unexposed and Uninfected Children in Uganda and Malawi: A Prospective Cohort Study
    Authors: Boivin, M., Maliwichi-Senganimalunje, L., Ogwang, W.L., Kawalazira, R., Sikorskii, A., Familiar-Lopez, I., Kuteesa, A., Nyakato, M., Mutebe, A., Namukooli, J.L., Mallewa, M., RuiseΓ±or-Escudero, H., Aizire, J., Taha, E.T., & Fowler, M.G.
    Year: 2019
    Citation: The Lancet HIV.
    Emojis: πŸ’ŠπŸ‘ΆπŸŒˆ
  • Title: Building Capacity in Neurodevelopment Assessment of Children in Sub-Saharan Africa: A Quality Assurance Model to Implement Standardized Neurodevelopment Testing
    Authors: RuiseΓ±or-Escudero, H., Familiar, I., Nyakato, M., Kutessa, A., Namukooli, J., Ssesanga, T., Joyce, C., Laughton, B., Grab, J., Chernoff, M., Vhembo, T., Fairlie, L., Kamthunzi, P., Boivin, M & the IMPAACT P1104s Team
    Year: 2018
    Citation: Child Neuropsychology, Journal on Normal and Abnormal Development in Childhood and Adolescence, 1-16.
    Emojis: πŸ“šπŸ§ πŸŒ
  • Title: Neurodevelopment of Ugandan and Malawian PROMISE Exposed and Unexposed Uninfected Children at 12 and 24 Months of Age
    Authors: Boivin, M.J., Malawichi-Senganimalunje, L., Nyakato, M., Sikorski, A., Ogwang, L.W., Kawalazira, R., Mallewa, M., Familiar-Lopez, I., Horacio, E., Aizire, J., Taha, T., & Fowler, M.G.
    Year: 2016
    Citation: Conference paper presented at the International AIDS Society Meeting, Durban, RSA.
    Emojis: πŸŽ“πŸ‘ΆπŸ‡ΏπŸ‡¦

Elena Kazali | Psychology | Best Researcher Award

Elena Kazali | Psychology | Best Researcher Award

Assistant Professor on tenure track of Cognitive-Experimental Psychology Department of Psychology, University of Ioannina, Greece

Elena Kazali is an accomplished Assistant Professor in Cognitive-Experimental Psychology at the University of Ioannina. With a strong emphasis on cognitive development and educational psychology, she combines academic rigor with a commitment to practical applications in educational settings. Her research explores the intricacies of cognitive processes, particularly in children, making significant contributions to understanding developmental psychology.

Profile:

Scopus Profile

Education

Elena earned her Doctor of Philosophy in Cognitive Development-Educational Psychology from Panteion University, achieving a “Distinction.” She also holds a Master’s Degree in Developmental Psychology from Lancaster University and a Bachelor’s degree in Psychology from Panteion University. This robust educational background has equipped her with the theoretical and practical knowledge necessary for her academic and research endeavors.

Professional Experience

Elena has extensive teaching experience at both undergraduate and postgraduate levels across several universities. She has contributed significantly to educational programs in psychology and special education, focusing on developmental psychology. Her roles include adjunct lecturer and tutor in various e-learning programs, demonstrating her versatility and dedication to student learning.

Research Interests

Elena’s research interests lie in cognitive development, language processing, and metacognition, particularly in preschool and school-aged children. She investigates how these cognitive processes influence educational outcomes and social adaptation, aiming to improve educational strategies for children with developmental challenges. Her work seeks to bridge theoretical research with practical applications in educational settings.

Award and Recognition

Elena received the Best Doctoral Thesis Award “Maria Nasiakou” from the Hellenic Psychological Society for her outstanding doctoral research. This recognition underscores her commitment to excellence in psychological research. Additionally, her participation in numerous national and international conferences showcases her dedication to advancing the field of psychology and her engagement with the academic community.

Publication Top Notes

  • Understanding the developmental needs of children with developmental language disorder according to professionals
    Authors: Ralli, A.M., Kalliontzi, E., Kazali, E., Palikara, O.
    Year: 2023
    Citation: In Childhood Developmental Language Disorders: Role of Inclusion, Families, and Professionals, pp. 159–174. πŸ“šπŸ‘Ά
  • Cognitive and linguistic factors in autism spectrum disorders
    Authors: Kazali, E., Koutsimani, P.
    Year: 2023
    Citation: In Developmental Language Disorders in Childhood and Adolescence, pp. 85–100. πŸ§ πŸ“–
  • Teachers’ Views of Children With Developmental Language Disorder in Greek Mainstream Schools
    Authors: Ralli, A.M., Kalliontzi, E., Kazali, E.
    Year: 2022
    Citation: Frontiers in Education, 7, 832240. 🌍🏫
  • Oral Language and Story Retelling During Preschool and Primary School Years: Developmental Patterns and Interrelationships
    Authors: Ralli, A.M., Kazali, E., Kanellou, M., et al.
    Year: 2021
    Citation: Journal of Psycholinguistic Research, 50(5), pp. 949–965. πŸ“–βœ¨
  • Oral language skills and psychosocial competence in early school-aged children of different language profiles
    Authors: Ralli, A.M., Kazali, E., Karatza, E.
    Year: 2021
    Citation: Psychology, 26(1), pp. 40–55. πŸ—£οΈπŸ‘¦πŸ‘§
  • Cognition and cognizance in preschool predict school achievement in primary school
    Authors: Demetriou, A., Kazali, E., Kazi, S., Spanoudis, G.
    Year: 2020
    Citation: Cognitive Development, 54, 100872. πŸ“ŠπŸ†
  • Cognizance in cognitive development: A longitudinal study
    Authors: Kazi, S., Kazali, E., Makris, N., Spanoudis, G., Demetriou, A.
    Year: 2019
    Citation: Cognitive Development, 52, 100805. πŸ”πŸ“…
  • Mapping the Dimensions of General Intelligence: An Integrated Differential-Developmental Theory
    Authors: Demetriou, A., Makris, N., Spanoudis, G., et al., Kazali, E.
    Year: 2018
    Citation: Human Development, 61(1), pp. 4–42. 🌐🧩
  • Developmental differentiation and binding of mental processes with g through the life-span
    Authors: Demetriou, A., Spanoudis, G., Kazi, S., et al., Kazali, E.
    Year: 2017
    Citation: Journal of Intelligence, 5(2), pp. 1–31. πŸ§ πŸ”—

Shruti Prajapati | electrical | Excellence in Research

Shruti Prajapati | electrical | Excellence in Research

Research Scholar, Delhi Technological University, India.

Shruti Prajapati is a dynamic researcher specializing in control techniques for renewable energy systems and power converters. Her expertise spans microgrids, solar photovoltaic systems, artificial neural networks, and optimization methods. Currently pursuing her Ph.D. at Delhi Technological University, she has made significant strides in energy management and innovative power control solutions. Prajapati’s research focuses on improving the efficiency and reliability of renewable energy resources, evidenced by her contributions to top-tier journals and conferences. Her work demonstrates a commitment to advancing sustainable energy technologies through innovation and practical applications.

Profile:

Scopus Profile

Education

Shruti Prajapati holds an M.Tech in Power Systems and Control from Birla Institute of Technology, Mesra, achieving an impressive 82.9%. She also completed her B.E. in Electrical & Electronics Engineering from M.S. Engineering College, Bangalore, with a score of 71.5%. Currently, she is pursuing her Ph.D. at Delhi Technological University. Her strong academic background is complemented by her skills in MATLAB, energy modeling, and control techniques for renewable energy systems.

Professional Experience

Prajapati has garnered experience in research and academic settings, particularly focusing on renewable energy systems and power electronics. Her skills in energy management, control techniques for solar PV and battery systems, and energy modeling have equipped her to handle complex challenges in microgrid systems. Her hands-on experience includes coding in MATLAB Simulink and control optimization techniques, which she has applied in both academic and industry-related projects. Her work integrates cutting-edge technologies with practical applications.

Research Interests

Prajapati’s research interests revolve around renewable energy resources, with a strong focus on microgrids, power converters, and optimization techniques. She is also deeply involved in exploring artificial neural networks and islanding detection methods in renewable systems. Her aim is to enhance the control and stability of energy systems, contributing to the field through advanced algorithms and control strategies for hybrid standalone microgrids and grid-integrated solar PV systems.

Award and Recognition

Shruti Prajapati has published in high-impact SCIE journals, including Electric Power Systems Research and Computers and Electrical Engineering. Her notable achievements include a Q1 category publication and several papers on control techniques for solar photovoltaic systems. In 2024, she co-authored a book chapter on network reconfiguration-based outage management. Additionally, she has presented her research at international conferences like the IEEE International Conference on Contemporary Computing and Informatics, further establishing her credentials in renewable energy research.

 

Publication Top Notes

  • Modified Control Approach for MPP Tracking and DC Bus Voltage Regulation in a Hybrid Standalone Microgrid
    • Author: Shruti Prajapati, R. Garg, P. Mahajan
    • Year: 2024
    • Citation: Electric Power Systems Research, 236, p.110935. πŸ”Œβš‘οΈ
  • Novel Adaptive MPPT Technique for Enhanced Performance of Grid Integrated Solar Photovoltaic System
    • Author: Shruti Prajapati, R. Garg, P. Mahajan
    • Year: 2024
    • Citation: Computers and Electrical Engineering. (Accepted) β˜€οΈπŸ”‹
  • Honey Badger Algorithm Based PI Controller for DC Link Voltage Control of Solar Photovoltaic System Connected to Grid for Enhanced Power Quality
    • Author: Shruti Prajapati, R. Garg, P. Mahajan
    • Year: 2024
    • Citation: Electric Power Components and Systems, pp.1-20. πŸ“ˆπŸ”§
  • Network Reconfiguration-Based Outage Management for Reliability Enhancement of Microgrid: A Hardware in Loop Approach
    • Author: Shruti Prajapati, S.K. Sahu, D. Ghosh
    • Year: 2024
    • Citation: In The Internet of Energy, pp. 337-357. πŸ“‘πŸŒ
  • Evolutionary Algorithm for Enhanced Performance of Grid Connected SPV System
    • Author: Shruti Prajapati, R. Garg, P. Mahajan
    • Year: 2022
    • Citation: In 2022 5th International Conference on Contemporary Computing and Informatics (IC3I), pp. 814-820. πŸŒžπŸ› οΈ

Sampatha Goonewardena| Cancer palliative care | Best Researcher Award

Sampatha Goonewardena| Cancer palliative care | Best Researcher Award

Professor in Community Medicine, University of Sri Jayewardenepura, Sri Lanka

Professor Christine Sampatha Evangeline Goonewardena is an accomplished academic and medical professional specializing in Community Medicine. With a career spanning over three decades, she has made substantial contributions to public health, particularly in maternal and child health, reproductive health, and public health education. As a professor at the University of Sri Jayewardenepura in Sri Lanka, she has led numerous research projects that have influenced health policies and improved community-level healthcare practices. Her work has garnered several national and international awards, underscoring her impact in public health. In addition to her research, she has held leadership positions and contributed to academic development through teaching and mentoring young researchers. Her publications, both individually and in collaboration, have addressed critical public health challenges and brought her widespread recognition in Sri Lanka and beyond. Professor Goonewardena’s dedication to improving healthcare outcomes reflects her commitment to academic excellence and community well-being.

Profile:

Scopus Profile

Education

Professor Goonewardena has an extensive educational background in medicine and public health. She earned her MBBS from North Colombo Medical College in Sri Lanka in 1990, laying the foundation for her medical career. She later pursued an MSc in Community Medicine from the Post Graduate Institute of Medicine, University of Colombo, in 1994, which included in-depth research on breastfeeding practices in urban slums. Her commitment to advancing community health led her to complete her MD in Community Medicine from the same institution in 2001, with a thesis focused on intrapartum and postpartum care in primary care settings. In 2003, she further specialized by obtaining a Diploma in Reproductive Health from the Liverpool School of Tropical Medicine, UK. This diverse academic background, combining clinical and public health expertise, has equipped her to address key health issues at both national and international levels.

Professional Experience

Professor Goonewardena has held various pivotal roles throughout her career in academia and public health. Currently, she serves as a Professor of Community Medicine at the Faculty of Medical Sciences, University of Sri Jayewardenepura, a position she has held since 2017. Before this, she served as a Senior Lecturer in the same department from 2002 to 2017, demonstrating her deep commitment to teaching and research. She also led the Department of Community Medicine as Head from 2006 to 2009 and again from 2012 to 2014. Earlier in her career, she worked as a Medical Officer specializing in Maternal and Child Health in the Colombo Municipality from 1991 to 1996. Her extensive work experience includes both clinical practice and academic roles, allowing her to bridge the gap between research and practical health solutions. She also serves as a Specialist Community Physician in the University Field Health Area.

Research Interests

Professor Goonewardena’s research interests primarily focus on maternal and child health, reproductive health, adolescent health, and health system improvements in low-resource settings. She has a particular interest in exploring ways to improve healthcare delivery at the community level, especially in underprivileged and rural areas. Her work has frequently addressed issues such as postpartum care, antenatal care, menstrual hygiene, and breastfeeding practices, aiming to provide evidence-based solutions to improve public health outcomes. In recent years, she has expanded her research to include mental health and cancer pain management, reflecting a holistic approach to healthcare that considers both physical and mental well-being. Her research is not only academically rigorous but also highly practical, often leading to recommendations that influence health policy and clinical practice in Sri Lanka.

Award and Recognition

Professor Goonewardena has been the recipient of numerous prestigious awards for her contributions to public health and research. In 2002, she received the Sir Nicholas Attygalle Award for her research on improving intrapartum and postpartum care. She has also been recognized with multiple Best Paper and Best Oral Presentation awards at national and international conferences, including the South Asian Association of Physiologists and the Sri Lanka Medical Association. In 2015, she won the Best Poster Award at the International Research Conference of Sir John Kotelawala Defence University for her work on antenatal care knowledge. Her achievements reflect both the depth and breadth of her research, with accolades in areas ranging from adolescent health to cancer pain management. These awards underscore her role as a leading researcher in community medicine, both within Sri Lanka and internationally.

 

Publication Top Notes

  • Delay among women reporting symptoms of breast cancer
    πŸ“ Authors: Kumari PBV, Goonewardena CSE
    πŸ“… Year: 2011
    πŸ“š Citation: JCCPSL, Vol 16, No 1, June 2011
  • Cancer: A hidden burden (Editorial)
    πŸ“ Author: Goonewardena CSE
    πŸ“… Year: 2011
    πŸ“š Citation: JCCPSL, Vol 16, No 1, June 2011
  • Extra-Curricular Activities and Factors Associated Among School-Going Adolescents in an Urban Area of Sri Lanka
    πŸ“ Authors: Weerasinghe IE, Gunawardana CSE, Jayatilake JAMS
    πŸ“… Year: 2014
    πŸ“š Citation: Global Education Review, Vol 2, No 2, February 2014, 72-82
  • Vaginal discharge: Women’s health-seeking behavior and cultural practices
    πŸ“ Authors: Ilankoon IMPS, Goonewardena CSE, Perera PPR, Fernandopulle RC
    πŸ“… Year: 2015
    πŸ“š Citation: International Journal of Current Research, Vol 7, Issue 6, June 2015
  • Quality of life of caregivers and impact on the nuclear family of children with leukaemia in the National Cancer Institute of Sri Lanka
    πŸ“ Authors: Pathirana TI, Goonewardena CSE, Wijesiriwardane I
    πŸ“… Year: 2015
    πŸ“š Citation: Journal of the Postgraduate Institute of Medicine, Vol 2: E18, 1-5
  • Factors associated with growth faltering in Sri Lankan infants: A case-control study in selected child welfare clinics in Sri Lanka
    πŸ“ Authors: Nevinda de Silva, Wijerathna K, Kahatapitiya S, Silva P, Perera R, Goonewardena S
    πŸ“… Year: 2015
    πŸ“š Citation: Journal of the Postgraduate Institute of Medicine, Vol 2: E19, 1-9
  • Public Health Midwives’ role in health education regarding vaginal discharge: A Cross-Sectional Descriptive Study
    πŸ“ Authors: Ilankoon IMPS, Goonewardena CSE, Fernandopulle RC, Perera PPR
    πŸ“… Year: 2016
    πŸ“š Citation: International Journal of Scientific Research and Management, Vol 4, Issue 06, 4303-4310
  • Pre-hospital care received by injured children less than five years admitted to the Lady Ridgeway Hospital for children, Colombo
    πŸ“ Authors: Gunawardhana YAGK, Goonewardena CSE
    πŸ“… Year: 2015
    πŸ“š Citation: Journal of the College of Community Physicians of Sri Lanka, Vol 21, No 1
  • Self-medication practices and misuse of medicine among mothers of young children attending a teaching hospital in Sri Lanka
    πŸ“ Authors: De Silva BP, Hussain FH, Ginige G, Kulathunge A, Kannangara H, Goonawardane S, Gamage M
    πŸ“… Year: 2017
    πŸ“š Citation: Sri Lanka Journal of Child Health, 46
  • Assessment of knowledge on the disease, its complications, and management strategies among hypertensive patients attending medical clinics at Teaching Hospital, Batticaloa, Sri Lanka
    πŸ“ Authors: Kisokanth G, Illankoon IMPS, Arulanandem K, Goonewardena CSE, Sundaresan KT, Joseph J
    πŸ“… Year: 2016
    πŸ“š Citation: Journal of the Postgraduate Institute of Medicine, Vol 3: E30, 1-1